Great to see this collaboration between @AstraZeneca and @UniofOxford which will enable the global development and distribution of the University’s potential recombinant adenovirus vaccine aimed at preventing COVID-19 infection from SARS-CoV-2. https://t.co/uBVT3vF3yu

— Sir Patrick Vallance (@uksciencechief) April 30, 2020